skip to main content
Idioma:

Diagnosis, Evaluation, and Management of the Hypertensive Disorders of Pregnancy: Executive Summary

Magee, Laura A., MD ; Pels, Anouk, MSc ; Helewa, Michael, MD ; Rey, Evelyne, MD ; von Dadelszen, Peter, MBChB

Journal of obstetrics and gynaecology Canada, 2014-05, Vol.36 (5), p.416-438 [Periódico revisado por pares]

Netherlands: Elsevier Inc

Texto completo disponível

Citações Citado por
  • Título:
    Diagnosis, Evaluation, and Management of the Hypertensive Disorders of Pregnancy: Executive Summary
  • Autor: Magee, Laura A., MD ; Pels, Anouk, MSc ; Helewa, Michael, MD ; Rey, Evelyne, MD ; von Dadelszen, Peter, MBChB
  • Assuntos: blood pressure ; Female ; Humans ; Hypertension ; Hypertension, Pregnancy-Induced - diagnosis ; Hypertension, Pregnancy-Induced - therapy ; long-term prognosis ; maternal outcome ; Obstetrics and Gynecology ; perinatal outcome ; preeclampsia ; Pregnancy
  • É parte de: Journal of obstetrics and gynaecology Canada, 2014-05, Vol.36 (5), p.416-438
  • Notas: ObjectType-Article-1
    SourceType-Scholarly Journals-1
    ObjectType-Instructional Material/Guideline-2
    ObjectType-Feature-3
    content type line 23
  • Descrição: Abstract Objective This executive summary presents in brief the current evidence assessed in the clinical practice guideline prepared by the Canadian Hypertensive Disorders of Pregnancy Working Group and published by Pregnancy Hypertension ( http://www.pregnancyhypertension.org/article/S2210-7789(14)00004-X/fulltext ) to provide a reasonable approach to the diagnosis, evaluation, and treatment of the hypertensive disorders of pregnancy. Evidence Published literature was retrieved through searches of Medline, CINAHL, and The Cochrane Library in March 2012 using appropriate controlled vocabulary (e.g., pregnancy, hypertension, pre-eclampsia, pregnancy toxemias) and key words (e.g., diagnosis, evaluation, classification, prediction, prevention, prognosis, treatment, postpartum follow-up). Results were restricted to systematic reviews, randomized control trials, controlled clinical trials, and observational studies published in French or English between January 2006 and February 2012. Searches were updated on a regular basis and incorporated in the guideline to September 2013. Grey (unpublished) literature was identified through searching the websites of health technology assessment and health technology-related agencies, clinical practice guideline collections, clinical trial registries, and national and international medical specialty societies. Values The quality of evidence in the guideline summarized here was rated using the criteria described in the Report of the Canadian Task Force on Preventative Health Care (Table 1).
  • Editor: Netherlands: Elsevier Inc
  • Idioma: Inglês;Francês
Links
Voltar para lista de resultados

  • Realização: ABCD-USP USP   Logos de Redes Sociais: Freepik

Buscando em bases de dados remotas. Favor aguardar.